Akihiro Sugawara

Dr. Akihiro Sugawara

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2019 in Nature
Verified
Journal Article
Closed access
PDF file
MLMaolin Lu
Maolin Lu
XMXiaochu Ma
Xiaochu Ma
LCLuis R. Castillo-Menendez
Luis R. Castillo-Menendez
JGJason Gorman
Jason Gorman
NANirmin Alsahafi
Nirmin Alsahafi
WMWalther Mothes
Walther Mothes

12 July 2019 in The Journal of Antibiotics
Verified
Journal Article
Closed access
DTDat Huu Tran
Dat Huu Tran
RSRyuichi Sugamata
Ryuichi Sugamata
THTomoyasu Hirose
Tomoyasu Hirose
SSShoichi Suzuki
Shoichi Suzuki
YNYoshihiko Noguchi
Yoshihiko Noguchi
KSKazuo Suzuki
Kazuo Suzuki

1 January 2011 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
JLJudith M. LaLonde
Judith M. LaLonde
MEMark A. Elban
Mark A. Elban
JCJoel R. Courter
Joel R. Courter
ASAkihiro Sugawara
Akihiro Sugawara
TSTakahiro Soeta
Takahiro Soeta
ASAmos B. Smith
Amos B. Smith

27 March 2009 in The Journal of Antibiotics
Verified
Journal Article
Closed access
THTomoyasu Hirose
Tomoyasu Hirose
TSToshiaki Sunazuka
Toshiaki Sunazuka
ASAkihiro Sugawara
Akihiro Sugawara
AEAyako Endo
Ayako Endo
KIKanami Iguchi
Kanami Iguchi
SŌSatoshi Ōmura
Satoshi Ōmura

9 November 2015 in International Journal of Oncology
Verified
Journal Article
Open access
PDF file
SMShuntaro Mukai
Shuntaro Mukai
SMShota Moriya
Shota Moriya
MHMasaki Hiramoto
Masaki Hiramoto
HKHiromi Kazama
Hiromi Kazama
HKHiroko Kokuba
Hiroko Kokuba
KMKeisuke Miyazawa
Keisuke Miyazawa
Pancreatic cancer is one of the most difficult types of cancer to treat because of its high mortality rate due to chemotherapy resistance. We previously reported that combined treatment with gefitinib (GEF) and clarithromycin (CAM) results in enhanced cytotoxicity of GEF along with endoplasmic reticulum (ER) stress loading in non-small cell lung cancer cell lines. An epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) such as GEF induces autophagy in a pro-survival role, whereas CAM inhibits autophagy flux in various cell lines. Pronounced GEF-induced cytotoxicity therefore appears to depend on the efficacy of autophagy inhibition. In the present study, we compared the effect on autophagy inhibition among such macrolides as CAM, azithromycin (AZM), and EM900, a novel 12-membered non-antibiotic macrolide. We then assessed the enhanced GEF-induced cytotoxic effect on pancreatic cancer cell lines BxPC-3 and PANC-1. Autophagy flux analysis indicated that AZM is the most effective autophagy inhibitor of the three macrolides. CAM exhibits an inhibitory effect but less than AZM and EM900. Notably, the enhancing effect of GEF-induced cytotoxicity by combining macrolides correlated well with their efficient autophagy inhibition. However, this pronounced cytotoxicity was not due to upregulation of apoptosis induction, but was at least partially mediated through necroptosis. Our data suggest the possibility of using macrolides as ‘chemosensitizers’ for EGFR-TKI therapy in pancreatic cancer patients to enhance non-apoptotic tumor cell death induction.

1 June 2011 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
ASAkihiro Sugawara
Akihiro Sugawara
ASAkito Sueki
Akito Sueki
THTomoyasu Hirose
Tomoyasu Hirose
KNKenichiro Nagai
Kenichiro Nagai
HGHiroaki Gouda
Hiroaki Gouda
TSToshiaki Sunazuka
Toshiaki Sunazuka